Due to significant variability among tumors and diversity in human immune types, developing immunotherapies for cancer is challenging. In a study published online in iGenome Research/i, researchers examined the largest collection of tumor samples to date to predict patient-specific tumor mutations that may activate the patient's immune system, paving the way for more successful, personalized cancer immunotherapy. Tumor cells accrue mutations in ...
Read More
No comments:
Post a Comment